We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NantHealth Inc | NASDAQ:NH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.35 | 1.39 | 0 | 01:00:00 |
NantHealth Announces Eviti Product Updates to Aid Efficiency and Reporting for Payers & NaviNet Product Updates to Enhance the User Experience
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will exhibit at the online America’s Health Insurance Plans (AHIP) Institute & Expo 2020, taking place June 16-18. NantHealth unveiled new Eviti® product updates to better assist payers as well as NaviNet® user interface to enhance the provider end user experience. The conference draws health insurance providers and decision makers from around the country to help drive quality, value and innovation.
At the conference, NantHealth is showcasing Eviti Connect, a world-class evidence-based treatment intelligence oncology platform that supports better decision making, and NaviNet Open, an industry-leading secure, multi-payer platform that elevates the payer-provider relationship from transactional to collaborative, enhancing communication and boosting operational efficiency.
Additionally, NantHealth unveiled two major Eviti product updates today:
“We continuously work to streamline treatment plan validation and operations, strengthening the foundation for better patient outcomes,” said Dr. William Flood, Chief Medical Officer for Eviti at NantHealth. “The challenges to cancer care delivery introduced by the COVID-19 pandemic have provided a unique opportunity to re-evaluate current processes and construct more valuable approaches for all our stakeholders: payers, patients, and providers.”
NantHealth also unveiled updates to NaviNet including:
As a follow-up to AHIP, NantHealth will be hosting two webinars this month. The first, A Look Ahead: The Pandemic’s Impact on Payers, is on Tuesday, June 23, 2020 at 2 p.m. EDT, led by NantHealth Chief Medical Officer, Eviti, Dr. William Flood, and NantHealth Regional Vice President, Raymond Wright, to discuss how payers are moving forward in this “new normal” as the healthcare industry continues to rapidly transform during the COVID-19 pandemic. The second, The Prior Authorization Edge, is on Tuesday, June 30, 2020 at 2 p.m. EDT, led by NantHealth Chief Medical Officer Dr. Sandeep “Bobby” Reddy, and NaviNet Vice President of Product Management and Strategy, Christina Perkins, to discuss how payers and providers can achieve workflow efficiencies, increase collaboration and deliver significant savings through the prior authorization process.
“As we all navigate these challenging times and look ahead, it’s essential to elevate the dialog and advance solutions that ease the burden while maintaining the benefits of prior authorizations for payers and providers,” said Christina Perkins, Vice President of Product Management and Strategy, NaviNet. “I look forward to discussing the intricacies with Dr. Reddy and hope you will join us for this conversation.”
NantHealth is focused on using data to close the loop – connecting payers, providers, and patients. Through its software, it facilitates the delivery of precise and timely data for creating efficiency, personalized treatment, and collaboration across healthcare.
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies, provides leading solutions across the continuum of care for physicians, payers, patients and biopharmaceutical organizations. NantHealth enables the use of cutting-edge data and technology toward the goals of empowering clinical decision support and improving patient outcomes. NantHealth’s comprehensive product portfolio combines the latest technology in payer/provider platforms that exchange information in near-real time (NaviNet and Eviti), and molecular profiling services that combine comprehensive DNA & RNA tumor-normal profiling with pharmacogenomics analysis (GPS Cancer®). For more information, please visit nanthealth.com or follow us on Twitter, Facebook and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200616005793/en/
MEDIA CONTACT NANT Jen Hodson Jen@nant.com 562-397-3639
1 Year NantHealth Chart |
1 Month NantHealth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions